the cloning of an antigen involved in transmission-blocking immunity , along with that of the surface antigen of the sporozoite ( csp ) and of a major surface antigen of the invasive merozoite ( pv200 ) constitutes a significant step towards the development of a multivalent recombinant vaccine against p. vivax .
C0003320
antigen
C0020964
immunity